Current Protocols最新文献

筛选
英文 中文
Chemical Synthesis of the Anti-COVID-19 Drug Remdesivir. 抗covid -19药物瑞德西韦的化学合成。
Current Protocols Pub Date : 2021-12-01 DOI: 10.1002/cpz1.303
Mo Wang, Lu Zhang, Xiaohong Huo, Zhenfeng Zhang, Wanbin Zhang
{"title":"Chemical Synthesis of the Anti-COVID-19 Drug Remdesivir.","authors":"Mo Wang,&nbsp;Lu Zhang,&nbsp;Xiaohong Huo,&nbsp;Zhenfeng Zhang,&nbsp;Wanbin Zhang","doi":"10.1002/cpz1.303","DOIUrl":"https://doi.org/10.1002/cpz1.303","url":null,"abstract":"<p><p>Remdesivir has become an important compound for the treatment of COVID-19. Here, we describe the catalytic asymmetric synthesis of this anti-COVID-19 drug. First, the P-racemic phosphoryl chloride is synthesized in a facile procedure. Then, it is possible to obtain the protected remdesivir via the organocatalytic asymmetric phosphorylation of protected nucleoside GS441524 with P-racemic phosphoryl chloride catalyzed by chiral bicyclic imidazole. Finally, remdesivir is easily prepared by deprotection. © 2021 Wiley Periodicals LLC. Basic Protocol 1: Synthesis of 2-ethylbutyl (chloro(phenoxy)phosphoryl)-L-alaninate rac-4 Basic Protocol 2: Synthesis of chiral bicyclic imidazole Ad-DPI Basic Protocol 3: Synthesis of remdesivir.</p>","PeriodicalId":11174,"journal":{"name":"Current Protocols","volume":" ","pages":"e303"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015308/pdf/CPZ1-1-e303.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39815169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Guinea Pig Model of Mycobacterium tuberculosis Infection. 豚鼠结核分枝杆菌感染模型。
Current Protocols Pub Date : 2021-12-01 DOI: 10.1002/cpz1.312
Elizabeth Creissen, Linda Izzo, Clinton Dawson, Angelo A Izzo
{"title":"Guinea Pig Model of Mycobacterium tuberculosis Infection.","authors":"Elizabeth Creissen,&nbsp;Linda Izzo,&nbsp;Clinton Dawson,&nbsp;Angelo A Izzo","doi":"10.1002/cpz1.312","DOIUrl":"https://doi.org/10.1002/cpz1.312","url":null,"abstract":"<p><p>Guinea pigs have been used as a model for Mycobacterium tuberculosis infection for many years and have been more recently adopted as a model for testing new tuberculosis (TB) vaccines. From the time of Robert Koch, who used guinea pigs to test theories about the newly discovered pathogen, the guinea pig has modeled active human infections, as it is susceptible to infection with low numbers of organisms. This article describes the modern use of the guinea pig to examine the pathology of the disease and the protocols used to examine specific outcomes associated with aerosol infection with virulent M. tuberculosis. The guinea pig is used extensively to investigate the ability of new TB vaccines to reduce TB disease, and two models have been employed. The first is the long-term disease model, in which vaccinated guinea pigs are monitored for disease after infection, and the second is the short-term assessment of mycobacterial burden model, which can determine the ability of a vaccine to reduce organism burden. © 2021 Wiley Periodicals LLC. Basic Protocol 1: Preparation of virulent Mycobacterium tuberculosis seed stocks for animal infections Basic Protocol 2: Preparation of virulent Mycobacterium tuberculosis working stocks for animal infections Basic Protocol 3: Preparation of M. tuberculosis for aerosol infection of guinea pigs Basic Protocol 4: Injection of guinea pigs Basic Protocol 5: Blood collection from live guinea pigs Basic Protocol 6: Guinea pig euthanasia.</p>","PeriodicalId":11174,"journal":{"name":"Current Protocols","volume":" ","pages":"e312"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39750597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Drug-releasing Microspheres for Stem Cell Differentiation. 用于干细胞分化的释药微球。
Current Protocols Pub Date : 2021-12-01 DOI: 10.1002/cpz1.331
Ruchi Sharma, Claire Benwood, Stephanie M Willerth
{"title":"Drug-releasing Microspheres for Stem Cell Differentiation.","authors":"Ruchi Sharma,&nbsp;Claire Benwood,&nbsp;Stephanie M Willerth","doi":"10.1002/cpz1.331","DOIUrl":"https://doi.org/10.1002/cpz1.331","url":null,"abstract":"<p><p>The ability of stem cells to differentiate into specialized cells make them a valuable tool for therapeutic applications. 3D bioprinting, a subset of additive manufacturing, uses bioinks composed of cells and biomaterials to create living tissues. The use of bioactive factors like small molecules and proteins can promote stem cell differentiation into the desired cell phenotypes for tissue regeneration. Small molecules can accelerate the process of regeneration in tissue engineering, maintain bioactivity in a biological environment, and minimize the costs associated with this process. Additionally, they can be encapsulated in specialized drug-delivery devices called microspheres for controlled release. Microspheres are small (1-1000 μm) spherical particles usually made from biodegradable and biocompatible polymers that can be loaded with drugs and other bioactive components. They can then be integrated into stem-cell-laden bioinks used to form bioprinted tissues, where they will release the encapsulated drug and promote differentiation of stem cells into the desired mature cell type. Microspheres can be widely used to encapsulate a broad range of therapeutic agents, including hydrophilic and hydrophobic small molecule drugs, DNA, and proteins. The release of encapsulated molecules occurs through degradation and erosion of the polymer matrix. This article provides detailed protocols for fabricating and sterilizing drug-releasing microspheres made from poly-ε-caprolactone, a promising biodegradable polymer often used for controlled drug delivery due to its biocompatibility and biodegradation kinetics. Additional protocols describe characterization of the loading and size of microspheres as well as incorporation of microspheres into a fibrin-based bioink for 3D bioprinting. © 2021 Wiley Periodicals LLC. Basic Protocol 1: Fabrication of drug-releasing PCL microspheres Support Protocol 1: Preparation of microspheres for determination of encapsulation efficiency by HPLC Support Protocol 2: Preparation of microspheres for SEM analysis Basic Protocol 2: Incorporation of microspheres into fibrin-based bioink.</p>","PeriodicalId":11174,"journal":{"name":"Current Protocols","volume":" ","pages":"e331"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39611459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Laboratory Maintenance of the Chytrid Fungus Batrachochytrium dendrobatidis. 壶菌水蛭壶菌的实验室养护。
Current Protocols Pub Date : 2021-12-01 DOI: 10.1002/cpz1.309
Sarah M Prostak, Lillian K Fritz-Laylin
{"title":"Laboratory Maintenance of the Chytrid Fungus Batrachochytrium dendrobatidis.","authors":"Sarah M Prostak,&nbsp;Lillian K Fritz-Laylin","doi":"10.1002/cpz1.309","DOIUrl":"https://doi.org/10.1002/cpz1.309","url":null,"abstract":"<p><p>The chytrid fungus Batrachochytrium dendrobatidis (Bd) is a causative agent of chytridiomycosis, a skin disease associated with amphibian population declines around the world. Despite the major impact Bd is having on global ecosystems, much of Bd's basic biology remains unstudied. In addition to revealing mechanisms driving the spread of chytridiomycosis, studying Bd can shed light on the evolution of key fungal traits because chytrid fungi, including Bd, diverged before the radiation of the Dikaryotic fungi (multicellular fungi and yeast). Studying Bd in the laboratory is, therefore, of growing interest to a wide range of scientists, ranging from herpetologists and disease ecologists to molecular, cell, and evolutionary biologists. This protocol describes how to maintain developmentally synchronized liquid cultures of Bd for use in the laboratory, how to grow Bd on solid media, as well as cryopreservation and revival of frozen stocks. © 2021 The Authors. Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Reviving cryopreserved Bd cultures Basic Protocol 2: Establishing synchronized liquid cultures of Bd Basic Protocol 3: Regular maintenance of synchronous Bd in liquid culture Alternate Protocol 1: Regular maintenance of asynchronous Bd in liquid culture Basic Protocol 4: Regular maintenance of synchronous Bd on solid medium Alternate Protocol 2: Starting a culture on solid medium from a liquid culture Basic Protocol 5: Cryopreservation of Bd.</p>","PeriodicalId":11174,"journal":{"name":"Current Protocols","volume":" ","pages":"e309"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39696846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Automated Quantification of Subcellular Particles in Myogenic Progenitors. 肌源性祖细胞亚细胞颗粒的自动定量分析。
Current Protocols Pub Date : 2021-12-01 DOI: 10.1002/cpz1.325
Romina L Filippelli, Amr Omer, Shulei Li, Chloë van Oostende-Triplet, Imed E Gallouzi, Natasha C Chang
{"title":"Automated Quantification of Subcellular Particles in Myogenic Progenitors.","authors":"Romina L Filippelli,&nbsp;Amr Omer,&nbsp;Shulei Li,&nbsp;Chloë van Oostende-Triplet,&nbsp;Imed E Gallouzi,&nbsp;Natasha C Chang","doi":"10.1002/cpz1.325","DOIUrl":"https://doi.org/10.1002/cpz1.325","url":null,"abstract":"<p><p>Fluorescence microscopy is a powerful tool enabling the visualization of protein localization within cells. In this article, we outline an automated and non-biased way to detect and quantify subcellular particles using immunocytochemistry, fluorescence microscopy, and the program CellProfiler. We discuss the examination of two types of subcellular particles: messenger ribonucleoprotein (mRNP) granules, namely processing bodies and stress granules, and autophagosomes. Fluorescent microscopy Z-stacks are acquired and deconvolved, and maximum intensity images are generated. The number of subcellular particles per cell is then quantified using the described CellProfiler pipeline. We also explain how to isolate primary myoblast progenitor cells from mice, which were used to obtain the presented results. Last, we discuss the critical parameters to be considered for each of these techniques. Both mRNP granules and autophagosomes play important roles in sequestering intracellular cargo, such as messenger RNAs and RNA-binding proteins for mRNP granules and cytoplasmic waste for autophagosomes. The methods outlined in this article are widely applicable for studies relating to subcellular particle formation, localization, and flux during homeostasis, following stimuli, and during disease. © 2021 The Authors. Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Immunofluorescence microscopy of messenger ribonucleoprotein granules in primary myoblasts Alternate Protocol: Immunofluorescence microscopy of autophagosomes in primary myoblasts Support Protocol: Isolation of primary myoblasts from mice Basic Protocol 2: Automated quantification of subcellular particles.</p>","PeriodicalId":11174,"journal":{"name":"Current Protocols","volume":" ","pages":"e325"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39702345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
CISH and IHC for the Simultaneous Detection of ZIKV RNA and Antigens in Formalin-Fixed Paraffin-Embedded Cell Blocks and Tissues. CISH和免疫组化同时检测福尔马林固定石蜡包埋细胞块和组织中寨卡病毒RNA和抗原。
Current Protocols Pub Date : 2021-12-01 DOI: 10.1002/cpz1.319
Sheryll Corchuelo, Claudia Y Gómez, Alicia A Rosales, Gerardo Santamaria, Jorge Alonso Rivera, Edgar Parra Saad, Orlando Torres-Fernández, Aura Caterine Rengifo
{"title":"CISH and IHC for the Simultaneous Detection of ZIKV RNA and Antigens in Formalin-Fixed Paraffin-Embedded Cell Blocks and Tissues.","authors":"Sheryll Corchuelo,&nbsp;Claudia Y Gómez,&nbsp;Alicia A Rosales,&nbsp;Gerardo Santamaria,&nbsp;Jorge Alonso Rivera,&nbsp;Edgar Parra Saad,&nbsp;Orlando Torres-Fernández,&nbsp;Aura Caterine Rengifo","doi":"10.1002/cpz1.319","DOIUrl":"https://doi.org/10.1002/cpz1.319","url":null,"abstract":"<p><p>Zika virus is an arthropod-borne virus that has recently emerged as a significant public health emergency due to its association with congenital malformations. Serological and molecular tests are typically used to confirm Zika virus infection. These methods, however, have limitations when the interest is in localizing the virus within the tissue and identifying the specific cell types involved in viral dissemination. Chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) are common histological techniques used for intracellular localization of RNA and protein expression, respectively. The combined use of CISH and IHC is important to obtain information about RNA replication and the location of infected target cells involved in Zika virus neuropathogenesis. There are no reports, however, of detailed procedures for the simultaneous detection of Zika virus RNA and proteins in formalin-fixed paraffin-embedded (FFPE) samples. Furthermore, the chromogenic detection methods for Zika virus RNA published thus far use expensive commercial kits, limiting their widespread use. As an alternative, we describe here a detailed and cost-effective step-by-step procedure for the simultaneous detection of Zika virus RNA and proteins in FFPE samples. First, we describe how to synthesize and purify homemade RNA probes conjugated with digoxygenin. Then, we outline the steps to perform the chromogenic detection of Zika virus RNA using these probes, and how to combine this technique with the immunodetection of viral antigens. To illustrate the entire workflow, we use FFPE samples derived from infected Vero cells as well as from human and mouse brain tissues. These methods are highly adaptable and can be used to study Zika virus or even other viruses of public health relevance, providing an optimal and economical alternative for laboratories with limited resources. © 2021 Wiley Periodicals LLC. Basic Protocol 1: Synthesis of RNA probes conjugated with digoxigenin (DIG) Basic Protocol 2: Simultaneous detection of ZIKV RNA and proteins in FFPE cell blocks and tissues.</p>","PeriodicalId":11174,"journal":{"name":"Current Protocols","volume":" ","pages":"e319"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39747281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Assembly of Multiple Full-Size Genes or Genomic DNA Fragments on Human Artificial Chromosomes Using the Iterative Integration System. 利用迭代集成系统在人工染色体上组装多个全尺寸基因或基因组DNA片段。
Current Protocols Pub Date : 2021-12-01 DOI: 10.1002/cpz1.316
Nicholas C O Lee, Nikolai S Petrov, Vladimir Larionov, Natalay Kouprina
{"title":"Assembly of Multiple Full-Size Genes or Genomic DNA Fragments on Human Artificial Chromosomes Using the Iterative Integration System.","authors":"Nicholas C O Lee,&nbsp;Nikolai S Petrov,&nbsp;Vladimir Larionov,&nbsp;Natalay Kouprina","doi":"10.1002/cpz1.316","DOIUrl":"https://doi.org/10.1002/cpz1.316","url":null,"abstract":"<p><p>Human artificial chromosomes (HACs) are gene delivery vectors that have been used for decades for gene functional studies. HACs have several advantages over viral-based gene transfer systems, including stable episomal maintenance in a single copy in the cell and the ability to carry up to megabase-sized genomic DNA segments. We have previously developed the alphoid<sup>tetO</sup> -HAC, which has a single gene acceptor loxP site that allows insertion of an individual gene of interest using Chinese hamster ovary (CHO) hybrid cells. The HAC, along with a DNA segment of interest, can then be transferred from donor CHO cells to various recipient cells of interest via microcell-mediated chromosome transfer (MMCT). Here, we detail a protocol for loading multiple genomic DNA segments or genes into the alphoid<sup>tetO</sup> -HAC vector using an iterative integration system (IIS) that utilizes recombinases Cre, ΦC31, and ΦBT. This IIS-alphoid<sup>tetO</sup> -HAC can be used for either serially assembling genomic loci or fragments of a large gene, or for inserting multiple genes into the same artificial chromosome. The insertions are executed iteratively, whereby each round results in the insertion of a new DNA segment of interest. This is accompanied by changes of expression of marker fluorescent proteins, which simplifies screening of correct clones, and changes of selection and counterselection markers, which constitutes an error-proofing mechanism that removes mis-incorporated DNA segments. In addition, the IIS-alphoid<sup>tetO</sup> -HAC carrying the genes can be eliminated from the cells, offering the possibility to compare the phenotypes of human cells with and without functional copies of the genes of interest. The resulting HAC molecules may be used to investigate biomedically relevant pathways or the regulation of multiple genes, and to potentially engineer synthetic chromosomes with a specific set of genes of interest. The IIS-alphoid<sup>tetO</sup> -HAC system is expected to be beneficial in creating multiple-gene humanized models with the purpose of understanding complex multi-gene genetic disorders. Published 2021. This article is a U.S. Government work and is in the public domain in the USA. Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Integration of the first DNA segment of interest into the IIS-alphoid<sup>teto</sup> -HAC Basic Protocol 2: Integration of a second DNA segment of interest into the IIS-alphoid<sup>teto</sup> -HAC Basic Protocol 3: Integration of a third DNA segment of interest into the IIS-alphoid<sup>teto</sup> -HAC Support Protocol: Fluorescence in situ hybridization analysis for the circular IIS-alphoid<sup>tetO</sup> -HAC.</p>","PeriodicalId":11174,"journal":{"name":"Current Protocols","volume":" ","pages":"e316"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3f/49/CPZ1-1-0.PMC8730363.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39596260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Correction: Cap 1 Messenger RNA Synthesis with Co-transcriptional CleanCap® Analog by In Vitro Transcription. 更正:Cap 1信使RNA合成与共转录CleanCap®类似物体外转录。
Current Protocols Pub Date : 2021-12-01 DOI: 10.1002/cpz1.336
Jordana M Henderson, Andrew Ujita, Elizabeth Hill, Sally Yousif-Rosales, Cory Smith, Nicholas Ko, Taylor McReynolds, Charles R Cabral, Julienne R Escamilla-Powers, Michael E Houston
{"title":"Correction: Cap 1 Messenger RNA Synthesis with Co-transcriptional CleanCap® Analog by In Vitro Transcription.","authors":"Jordana M Henderson,&nbsp;Andrew Ujita,&nbsp;Elizabeth Hill,&nbsp;Sally Yousif-Rosales,&nbsp;Cory Smith,&nbsp;Nicholas Ko,&nbsp;Taylor McReynolds,&nbsp;Charles R Cabral,&nbsp;Julienne R Escamilla-Powers,&nbsp;Michael E Houston","doi":"10.1002/cpz1.336","DOIUrl":"https://doi.org/10.1002/cpz1.336","url":null,"abstract":"","PeriodicalId":11174,"journal":{"name":"Current Protocols","volume":" ","pages":"e336"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39696848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Synthesis of 6-Aza-2-Hydroxyimino-5-Methylpyrimidine Nucleosides for Antiviral Evaluation. 6-叠氮-2-羟亚胺-5-甲基嘧啶核苷的合成及其抗病毒评价
Current Protocols Pub Date : 2021-12-01 DOI: 10.1002/cpz1.329
Reham A I Abou-Elkhair, Jinxi Du, Abdalla A Wasfy, Nisrin A Khaill, Hend M Maaroof, Marwa H Hassan, Ayman S Ahmed, Abdalla E A Hassan, Jia Sheng
{"title":"Synthesis of 6-Aza-2-Hydroxyimino-5-Methylpyrimidine Nucleosides for Antiviral Evaluation.","authors":"Reham A I Abou-Elkhair,&nbsp;Jinxi Du,&nbsp;Abdalla A Wasfy,&nbsp;Nisrin A Khaill,&nbsp;Hend M Maaroof,&nbsp;Marwa H Hassan,&nbsp;Ayman S Ahmed,&nbsp;Abdalla E A Hassan,&nbsp;Jia Sheng","doi":"10.1002/cpz1.329","DOIUrl":"https://doi.org/10.1002/cpz1.329","url":null,"abstract":"<p><p>The syntheses of a series of novel 6-aza-2-hydroxyimino-5-methylpyrimidine and related nucleosides are described. A suitably protected 2-methylthiopyrimidine nucleoside was selected as the precursor for installing a hydroxyimino moiety at the C-2 position. The starting nucleobase 6-aza-5-methyl-2-thiouracil is prepared in two steps from thiosemicarbazone and ethyl pyruvate. This is subjected to coupling with 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose under Vorbrüggen glycosylation conditions to provide the corresponding nucleoside in high yield. Activation of the nucleoside to the corresponding 2-methylthio derivative followed by treatment with hydroxylamine hydrochloride in pyridine provides the corresponding 2-hydroxyimino derivative in high yield. Finally, the synthesis of five free modified nucleoside analogs is described. The newly synthesized nucleosides have been evaluated against an RNA viral panel and moderate activity was observed against hepatitis C virus, Zika virus, and human respiratory syncytial virus. © 2021 Wiley Periodicals LLC. Basic Protocol 1: Preparation of 6-aza-5-methyl-2-thiouracil Basic Protocol 2: Preparation of 6-aza-5-methyl-2-thiouridine and 6-aza-5-methyluridine Basic Protocol 3: Preparation of 6-aza-2-hydroxyimino-5-methyluridine Basic Protocol 4: Preparation of 6-aza-2-hydroxyimino-5-methyl-4-thiouridine and 6-aza-2-hydroxyimino-5-methylcytosine.</p>","PeriodicalId":11174,"journal":{"name":"Current Protocols","volume":" ","pages":"e329"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39956533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Collagen-Induced Arthritis Mouse Model. 胶原诱导关节炎小鼠模型。
Current Protocols Pub Date : 2021-12-01 DOI: 10.1002/cpz1.313
Edward F Rosloniec, Karen Whittington, Amanda Proslovsky, David D Brand
{"title":"Collagen-Induced Arthritis Mouse Model.","authors":"Edward F Rosloniec,&nbsp;Karen Whittington,&nbsp;Amanda Proslovsky,&nbsp;David D Brand","doi":"10.1002/cpz1.313","DOIUrl":"https://doi.org/10.1002/cpz1.313","url":null,"abstract":"<p><p>The collagen-induced arthritis mouse model is a widely studied autoimmune model of rheumatoid arthritis. In this model, autoimmune arthritis is induced by immunization of genetically susceptible strains of mice with type II collagen emulsified in complete Freund's adjuvant. This article describes the steps necessary for the acquisition, handling, and preparation of CII, in addition to the selection of mouse strains, proper immunization technique, and methods for evaluation of the incidence and severity of the autoimmune arthritis. In this model, the first signs of arthritis appear approximately 21 to 28 days after immunization. The protocols in this article should provide the investigator with all the necessary information required to reproducibly induce a high incidence of CIA in genetically susceptible strains of mice, and to critically evaluate the pathology of the disease. Published 2021. This article is a U.S. Government work and is in the public domain in the USA. Basic Protocol: Induction of collagen-induced arthritis Support Protocol 1: Purification of type II collagen Support Protocol 2: Purification of type II collagen α1(II) chains Support Protocol 3: Assessment of arthritis incidence and severity Support Protocol 4: Measurement of CII specific antibody by indirect ELISA Support Protocol 5: Coupling CII to magnetic beads Support Protocol 6: Measuring CII-specific antibody by magnetic-bead based ELISA Support Protocol 7: Measurement of T cell responses to CII in CIA.</p>","PeriodicalId":11174,"journal":{"name":"Current Protocols","volume":" ","pages":"e313"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39712155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信